# Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia

> **NCT05104099** · PHASE2 · COMPLETED · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 17 (actual)

## Conditions studied

- Vulvar Intraepithelial Neoplasia
- Vulvar High Grade Squamous Intraepithelial Lesion
- Differentiated Vulvar Intraepithelial Neoplasia

## Interventions

- **DRUG:** Metvixia Topical Cream

## Key facts

- **NCT ID:** NCT05104099
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-29
- **Primary completion:** 2024-06-27
- **Final completion:** 2025-05-25
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05104099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05104099, "Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05104099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*